Featured Stories
Stada to commercialize Rowiren in Nordic region
We are very excited to announce our new collaboration with STADA Nordic.
Read MoreAAA Gold Creditworthiness Certificate of Excellence for Medis Adria
The certificate confirms the company’s international standard of creditworthiness excellence and reliable business in Croatia.
Read MoreBIAL and Medis entered into a partnership for innovative medicines for the central nervous system
BIAL and Medis announce that they have entered into an exclusive partner-ship on two BIAL's proprietary medicines eslicarbazepine acetate and opicapone.
Read MoreHeartily for a better tomorrow, interview with Marija Delimar, director of Medis Adria d.o.o., Croatia
In more than 30 years of business, Medis has established important cooperation with leading global pharmaceutical and biotechnological companies. We talked with...
Read MoreTo Celebrate the 15th Anniversary of Medis International BiH, the Employees Planted 15 Conifers on the Slopes of Igman
On this occasion, the Bosnian Medis team briefly left the offices and replaced the office environment with nature.
Read MoreMedis' Bold Strategy Opens Up Access to Cutting-Edge Innovative Medicines in the CEE Region
Strategic business units reflect focus, expertise and reliable service. Medis rebranding reveals passion and compassion to address the emerging healthcare needs...
Read More